Literature DB >> 16215846

Effect of P-selectin inhibition on leukocyte-endothelium interaction and survival after global cerebral ischemia.

Jens Lehmberg1, Jürgen Beck, Alexander Baethmann, Eberhard Uhl.   

Abstract

Cerebral ischemia induces activation of leukocyte-endothelium interactions requiring upregulation of specific adhesion molecules including the selectins. The aim of the current study was to elucidate the therapeutic potency of P-selectin blockade on microcirculatory disturbances and secondary brain damage after global cerebral ischemia. Global cerebral ischemia for 15 minutes was induced in Mongolian gerbils. Functional blockade of P-selectin was achieved by pretreatment with the antibody RB 40.34 (2 mg/kg, n = 7). In vivo observation of brain microcirculation was performed by epifluorescence microscopy of a cranial window. Survival was assessed daily up to 4 days after ischemia. In the control group leukocyte rolling increased during reperfusion with a maximum at 3 h (28 +/- 14 x 100 microm(-1) x min(-1)) and was significantly reduced by the P-selectin antibody (13 +/- 9 x 100 microm(-1) x min(-1), p < 0.05). No effect on firm leukocyte adhesion was observed (4 +/- 3 vs. 2 +/- 1 x 100 microm(-1) x min(-1)). The survival of animals that received the Pselectin antibody (28 %) was significantly reduced compared with controls (71 %). Anti-P-selectin antibody reduces leukocyte rolling but has no positive effect on survival. Our data question the role of the inflammatory response in the development of secondary brain damage and do not support this kind of therapeutical approach in global cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215846     DOI: 10.1007/s00415-005-0996-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

Review 1.  Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil.

Authors:  C R Welbourn; G Goldman; I S Paterson; C R Valeri; D Shepro; H B Hechtman
Journal:  Br J Surg       Date:  1991-06       Impact factor: 6.939

2.  Determinants of survival after forebrain ischemia in Mongolian gerbils.

Authors:  K Weber; A Baethmann; O Kempski
Journal:  Metab Brain Dis       Date:  1988-12       Impact factor: 3.584

3.  Delayed hypoperfusion after incomplete forebrain ischemia in the rat. The role of polymorphonuclear leukocytes.

Authors:  B Grøgaard; L Schürer; B Gerdin; K E Arfors
Journal:  J Cereb Blood Flow Metab       Date:  1989-08       Impact factor: 6.200

4.  Anti-P-selectin antibody attenuates rat brain ischemic injury.

Authors:  H Suzuki; T Hayashi; S J Tojo; H Kitagawa; K Kimura; M Mizugaki; Y Itoyama; K Abe
Journal:  Neurosci Lett       Date:  1999-04-23       Impact factor: 3.046

5.  Role of P-selectin in the migration of neutrophils to chemoattractant-induced cutaneous inflammation in mice.

Authors:  M Ohnishi; N Imanishi
Journal:  Inflammation       Date:  2000-12       Impact factor: 4.092

6.  Capillary perfusion during incomplete forebrain ischemia and reperfusion in rat brain.

Authors:  H Theilen; H Schröck; W Kuschinsky
Journal:  Am J Physiol       Date:  1993-08

7.  Leukocyte involvement in cerebral ischemia and reperfusion injury.

Authors:  U S Vasthare; L A Heinel; R H Rosenwasser; R F Tuma
Journal:  Surg Neurol       Date:  1990-04

8.  Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia.

Authors:  W Stummer; K Weber; B Tranmer; A Baethmann; O Kempski
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

Review 9.  Ischemia-mediated neuronal injury.

Authors:  K A Hossmann
Journal:  Resuscitation       Date:  1993-12       Impact factor: 5.262

10.  Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L-selectin.

Authors:  D Nolte; P Schmid; U Jäger; A Botzlar; F Roesken; R Hecht; E Uhl; K Messmer; D Vestweber
Journal:  Am J Physiol       Date:  1994-10
View more
  10 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 2.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Inflammation and NFkappaB activation is decreased by hypothermia following global cerebral ischemia.

Authors:  Carla M Webster; Stephen Kelly; Maya A Koike; Valerie Y Chock; Rona G Giffard; Midori A Yenari
Journal:  Neurobiol Dis       Date:  2008-11-19       Impact factor: 5.996

Review 4.  Role of inflammation and its mediators in acute ischemic stroke.

Authors:  Rong Jin; Lin Liu; Shihao Zhang; Anil Nanda; Guohong Li
Journal:  J Cardiovasc Transl Res       Date:  2013-09-05       Impact factor: 4.132

Review 5.  The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.

Authors:  Bolanle M Famakin
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

Review 6.  [Post-resuscitation syndrome. Role of inflammation after cardiac arrest].

Authors:  A Schneider; M Albertsmeier; B W Böttiger; P Teschendorf
Journal:  Anaesthesist       Date:  2012-05       Impact factor: 1.041

Review 7.  Novel uses for anti-platelet agents as anti-inflammatory drugs.

Authors:  S C Pitchford
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

Review 8.  Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade.

Authors:  Łukasz Przykaza
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 9.  Hypothermia and brain inflammation after cardiac arrest.

Authors:  Pouya Tahsili-Fahadan; Salia Farrokh; Romergryko G Geocadin
Journal:  Brain Circ       Date:  2018-04-18

Review 10.  Targeting vascular inflammation through emerging methods and drug carriers.

Authors:  Jia Nong; Patrick M Glassman; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2022-03-07       Impact factor: 17.873

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.